ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02688985
Brief Title: Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

First Submitted : February 18, 2016
First Submitted that Met QC Criteria : February 18, 2016
First Posted : February 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 5, 2018
Last Update Posted : December 6, 2018